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Abstract
Human studies have demonstrated that physiologically relevant changes in circulat-
ing glucagon-like peptide-1 (GLP-1) elicit a rapid increase in renal sodium excretion 
when combined with expansion of the extracellular fluid volume. Other studies sup-
port the involvement of various gastrointestinal hormones, e.g., gastrin and chol-
ecystokinin (CCK) in a gut-kidney axis, responsible for a rapid-acting feed-forward 
natriuretic mechanism. This study was designed to investigate the hypothesis that the 
postprandial GLP-1 plasma concentration is sensitive to the sodium content in the 
meal. Under fixed sodium intake for 4 days prior to each experimental day, 10 lean 
healthy male participants were examined twice in random order after a 12-hr fasting 
period. Arterial blood samples were collected at 10–20-min intervals for 140 min 
after 75 grams of oral glucose + 6 grams of oral sodium chloride (NaCl) load versus 
75 grams of glucose alone. Twenty-four-hour baseline urinary sodium excretions 
were similar between study days. Arterial GLP-1 levels increased during both oral 
glucose loads and were significantly higher at the 40–80  min period during glu-
cose + NaCl compared to glucose alone. The postprandial arterial responses of CCK, 
gastrin, and glucose-dependent insulinotropic polypeptide as well as glucose, insulin, 
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1 |  INTRODUCTION
Hypertension is one of the most common and important 
health problems worldwide because of its high frequency 
and concomitant risks of cardiovascular and kidney disease 
(Kearney et al., 2005; Mills et al., 2016). It has been esti-
mated that about 30% of the world's adult population will 
have hypertension by the year 2025 (Kearney et al., 2005; 
Mills et al., 2016). Hypertension is caused by genetic and 
epigenetic predisposition and modified by environmental 
influences and sedentary lifestyles. There is overwhelming 
evidence that high dietary sodium intake increases the risk 
for incident hypertension and leads to worse cardiovascu-
lar outcomes in established hypertension (Farquhar et al., 
2015; Whelton et  al.,  2012). While the kidneys regulate 
sodium balance and blood pressure, the gastrointestinal 
(GI) tract has taste/nutrient sensing receptors and sensors 
for electrolytes (e.g. sodium, potassium, phosphate) partly 
coupled to release of GI hormones (Furness et al., 2013). 
Previous studies support the involvement of a gut-kidney 
axis in the excretion of a dietary sodium load mediated by GI 
hormones, including gastrin and CCK, possibly through in-
teraction with renal dopamine receptors (Chen et al., 2013; 
Liu & Jose, 2013; Liu et al., 2016). Thus, there is increas-
ing evidence of the importance of the GI tract in blood 
pressure regulation potentially through feed-forward ef-
fects on renal sodium handling. Recently, we demonstrated 
a natriuretic effect of another GI hormone, glucagon-like 
peptide-1 (GLP-1) after extracellular fluid volume expan-
sion. The response was associated with suppression of an-
giotensin II (ANG II) and independent of renal plasma flow 
and glomerular filtration rate (Asmar et  al.,  2015, 2016, 
2019). Because GLP-1 release is physiologically regulated 
by luminal stimuli in the small intestine, and since salt in-
take varies strongly within and between individuals, a di-
rect salt sensitivity of L-cell GLP-1 release could provide 
a sequential, feed-forward signal that adds to the gastric/
duodenal signals from gastrin/CCK for renal sodium ex-
cretion. Whether the L-cell has sensors for sodium cou-
pled to release of GLP-1 is not clarified. Specifically, this 
randomized, controlled cross-over study was designed to 
investigate the hypothesis that postprandial GLP-1 plasma 
concentrations are sensitive to an increased NaCl intake, 
supporting a feed-forward natriuretic system.
2 |  MATERIALS AND METHODS
2.1 | Design
The study protocol had a randomized, cross-over design 
with a washout period of ~2  weeks. Each subject served 
as his own control and was studied on two different occa-
sions during an oral load of 75 grams of glucose + 6 grams 
of sodium chloride (NaCl) or a 75 grams of glucose load 
alone (Figure 1).
and C-peptide did not differ between the two study days. Arterial renin, aldoster-
one, and natriuretic peptides levels did not change within subjects or between study 
days. Angiotensin II levels were significantly lower at the time GLP-1 was higher 
(60–80 min) during glucose + NaCl. Sodium intake in addition to a glucose load se-
lectively amplifies the postprandial GLP-1 plasma concentration. Thus, GLP-1 may 
be part of an acute feed-forward mechanism for natriuresis.
K E Y W O R D S
Glucagon-like peptide-1, gut, gut-kidney axis, kidney, the renin-angiotensin-aldosterone system
F I G U R E  1  Timeline and the study design. The study was an observational, open-label, cross-over, dietary intervention with standard oral 
glucose load with and without 6 g of NaCl
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2.2 | Participants
Baseline characteristics are shown in Table 1. Eleven young 
male participants completed the study. All participants were 
healthy and none took medication at the time of the study. 
Body composition was determined by dual energy X-ray ab-
sorptiometry (DXA) scanning (Lunar iDXA; GE Healthcare, 
Brøndby, Denmark) (Table  1). Consent to participate was 
obtained after the participants had read a description of the 
experimental protocol, which was approved by the Scientific 
Ethics Committee of the Capital region of Copenhagen (H-
17030187). One participant was excluded from the study due 
to a pathological oral glucose tolerance test. This study was 
not registered on clinicaltrials.gov, because it was considered 
as a kinetic observational study with oral ingestion of normal 
dietary components (salt and sugar) and pure observational 
measurements.
2.3 | Protocol
For 4 days before each experiment, all participants consumed 
a controlled mixed diet (2,822  kcal per day; 16% protein, 
55% carbohydrate, 29% fat) (Figure 1). The food was handed 
out frozen, and the sodium chloride (NaCl) content of the 
diet, measured at Eurofins Stein's Laboratory in Denmark, 
was 55–75  mmol per day. NaCl was added to the diet in 
order to standardize daily intake at 2 mmol NaCl per kg body 
weight per day. Twenty-four-hour urine was collected on the 
last day, and electrolytes, glucose, creatinine, and albumin 
concentrations were determined. Water intake was ad libi-
tum, and strenuous physical activity was not allowed during 
the 4-day period.
Participants fasted for 12  hr before the beginning 
of the experiments around 9 a.m. After emptying the 
bladder, confirmed by ultrasound, participants remained su-
pine throughout the experiments. A radial artery was cath-
eterized with a 20-gauge catheter (BD Arterial Cannula®: 
1.1  mm OD, length 45  mm, Becton Dickinson, Franklin 
Lakes, New Jersey, USA) for blood sampling. After approx-
imately 45 min of rest in supine position, two baseline blood 
samples were drawn followed by an oral load of 75 grams of 
glucose (416 mmol) + 6 grams of NaCl (103 mmol) or a 75 
grams of glucose load alone; both were dissolved in 500 mL 
tap water. The solutions were prepared freshly and ingested 
within 5 min. Six grams of NaCl corresponding to 103 mmol 
was chosen, because it corresponded to the high-normal con-
tent of a major western diet meal.
2.4 | Blood and urine analyses
Blood was collected from the radial artery throughout the ex-
periments (0–140 min) every 10 min for the first 40 min and 
thereafter every 20 min for the remaining experiment. The 
amount of total collected blood (~165 mL) on each study day 
was carefully substituted with a similar amount of isotonic 
saline during the experiments.
Arterial blood samples were analyzed for GLP-1, GIP, 
CCK, gastrin, insulin, C-peptide, renin, ANG II, aldosterone, 
pro atrial natriuretic peptide (ANP), ANP, brain natriuretic 
peptide (BNP), glucose, sodium, chloride, hydrogen, potas-
sium, hematocrit, and oxygen saturation.
Plasma samples were assayed for total GLP-1 and 
GIP immunoreactivity as previously described (Lindgren 
et  al., 2011; Orskov et al., 1994). Gastrin concentrations in 
plasma were measured, using a radioimmunoassay (RIA) 
that is specific without cross reactivity with any CCK peptide 
(Stadil & Rehfeld, 1973), and CCK concentrations in plasma 
were measured with a specific RIA without cross reactivity 
with any gastrin peptide (Rehfeld, 1998).
Plasma renin concentrations were measured by RIA of an-
giotensin I (ANG I) through the antibody-trapping method of 
Poulsen and Jørgensen (Poulsen & Jorgensen, 1974), using eth-
ylenediaminetetraacetic acid (EDTA) plasma (100 μL) incubated 
with plasma from a nephrectomized sheep for 3 hr as previously 
described. Concentrations were measured by the rate of ANG I 
formation and standardized in terms of international units per liter 
(IU/L) according to the activity of the WHO International Standard 
(ref. no. 68–356; National Institute for Biological Standards and 
Control, Hertfordshire, UK) of which samples of 0.05 IU/L were 
included in every run of the renin assay. In the period where mea-
surements were performed, 1  IU of the WHO standard corre-
sponded to 32 ± 5 ng ANG I per hr. Between-assay coefficient 
of variation (CV) was 15%. ANG II peptide hormone concentra-
tions in plasma were measured by RIA (using specific antibodies 
and charcoal plasma to separate bound antigen from free) after 
extraction performed by use of Sep-Pak C18 columns (Waters, 
T A B L E  1  – Baseline characteristics of participants
Variable Value
Number of participants 10
Age (year) 25 ± 4
Height (cm) 179 ± 4
Weight (kg) 72.8 ± 7.7
Lean body mass (kg) 58.4 ± 4.2
Whole body fat mass (kg) 14.4 ± 5.8
Systolic blood pressure (mm Hg) 119 ± 12
Diastolic blood pressure (mm Hg) 75 ± 6
Heart rate (bpm) 72 ± 8
Fasting glucose concentration (mmol/L) 5.1 ± 0.1
Fasting insulin concentration (pmol/L) 74 ± 14
Note: Body composition was determined by dual energy X-ray absorptiometry 
(DXA) scanning. Data are presented as means ± SD.
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Millipore Corporation, Milford, MA, USA) based on antibody 
Ab-5–030682 raised in rabbits (Bie & Sandgaard, 2000). Briefly, 
plasma was incubated with antibody (final dilution of 1:1,000,000) 
and tracer 125I-labeled ANG II (Department of Clinical Physiology, 
Nuclear Medicine and PET, Rigshospitalet, University Hospital 
of Copenhagen, Denmark). Blood samples for ANG II analy-
ses were collected in EDTA tubes prepared with 150 μL of 1, 
10-Phenantrolin Monohydrate. Plasma aldosterone concentrations 
were measured, using a commercial ELISA (MS E-5200, Labor 
Diagnostika Nord GmbH & Co. KG, Germany). EDTA plasma 
was incubated with Aldosterone HRP conjugate for 1 hr as de-
scribed by the manufacturer and was subjected to the standard pro-
cedure in the instructions. A human EDTA plasma pool was used 
as an internal standard (79 ± 8 pg/mL). Between-assay coefficient 
of variation was 10%. Plasma proANP, ANP and BNP were mea-
sured by ELISA kits (CUSABIO, Baltimore, USA). The intraassay 
CV was < 8% for each peptide measured, and the interassay CV 
was < 4% for proANP and < 10% for ANP and BNP. Blood sam-
ples for proANP, ANP, and BNP analyses were collected in EDTA 
tubes prepared with 62.5 μL of 1,10-Phenantrolin Monohydrate.
Insulin and C-peptide levels in plasma were measured, using 
commercial ELISA (Insulin Human ELISA EIA-2935 and 
C-peptide ELISA EIA-1293, AH Diagnostics, Aarhus, Denmark).
Plasma electrolyte (Na+, Cl-, H+, K+) concentrations, 
glucose, hematocrit, and oxygen saturation were measured, 
using an automated benchtop blood analyzer system (ABL 
700 series, Radiometer Medical Aps, Brønshøj, Denmark).
Urinary electrolyte (Na+, K+) concentrations were mea-
sured by atomic absorption (Atomic absorption spectropho-
tometer model 2,380, PerkinElmer, Norwalk, Connecticut). 
Urinary pH was measured, using a XC161 Combination pH 
electrode (Radiometer Medical Aps).
2.5 | Calculations
Twenty-four-hour urinary excretions were calculated from 
the actual collection time and presented on a 24-hr basis as 
follows: electrolyte excretion (Vx) = Ux ∙ Vu, where Ux is the 
concentration of substance X in urine, and Vu is the 24-hr 
urine volume.
2.6 | Statistical analysis
The primary endpoint in this study was the postprandial GLP-1 
plasma concentration response. When we used a two-tailed 
α = 0.05 and an 80% power threshold, a sample size of n = 9 
was calculated to be needed to detect an appreciable effect of 
a NaCl load in addition to a glucose load on postprandial cir-
culatory levels of GLP-1. Data were analyzed, using GraphPad 
Prism 8 (GraphPad Software Inc. La Jolla, CA, USA). Area 
under the curve (AUC) was calculated using the trapezoidal 
rule, and the t-test (2-tailed) for paired data was used for com-
paring incremental AUC values between the two study days. 
Values of p < .05 were considered statistically significant. We 
confirmed that data on hormone and electrolyte levels in this 
study passed the Shapiro–Wilk test (GraphPad Software Inc.) 
for normal distribution.
3 |  RESULTS
3.1 | Standardized sodium chloride intake
All participants completed the mixed controlled diet with 
fixed NaCl intake for 4  days prior to each experiment, 
and all 24-hr urine collections were successfully com-
pleted with similar mean collection time on each study day 
(23.8 ± 0.6 hr versus 23.3 ± 0.3 hr, p = .575). On the last 
day of the 4-day period with standardized NaCl intake and 
just before each study day, 24-hr urine data were statisti-
cally similar, and mean urinary sodium excretion was not 
different from the calculated expected amount ~ 140 mmol 
(Table 2).
3.2 | Effect of glucose and sodium chloride 
intake on arterial plasma concentrations of 
glucose, insulin, and C-peptide
None of the participants complained about abdominal dis-
comfort specifically during the NaCl load. Arterial plasma 
concentrations of glucose, insulin, and C-peptide increased 
Urine variable
Baseline 
(glucose + NaCl)
Baseline 
(glucose) p-value
Number of participants 10 10 ---
Volume (mL/24-hr) 1,560 ± 200 1,628 ± 212 .451
Sodium (mmol/24-hr) 133 ± 11 132 ± 11 .879
pH 5.9 ± 0.1 5.8 ± 0.1 .439
Potassium (mmol/24-hr) 60 ± 6 59 ± 6 .986
Note: Twenty-four-hour urinary excretions were calculated from the actual collection time (23.8 ± 0.6 hr 
versus 23.3 ± 0.3 hr, p = .575) and presented on a 24-hr basis. Data are presented as means ± SE.
T A B L E  2  – 24-hr urinary excretions 
during baseline
   | 5 of 11ASMAR et Al.
similarly during glucose  +  NaCl and glucose alone 
(Figure 2a-c).
3.3 | Effect of glucose and sodium chloride 
intake on arterial plasma concentrations of 
sodium, chloride, potassium, hydrogen, 
calcium, and hematocrit
Arterial plasma concentrations of sodium increased during 
glucose  +  NaCl and glucose alone compared to baseline, 
however, the increase was significantly higher during glu-
cose  +  NaCl compared with glucose (Figure  3a). Plasma 
concentrations of chloride and hydrogen only increased sig-
nificantly during glucose + NaCl (Figure 3b and c). Plasma 
potassium concentrations decreased similarly during during 
glucose + NaCl and glucose alone (Figure 3d). Plasma con-
centrations of calcium, and hematocrit remained unchanged 
during glucose  +  NaCl compared with glucose alone 
(Figure 3e and f).
3.4 | Effect of glucose and sodium chloride 
intake on arterial plasma concentrations of 
GLP-1, GIP, CCK, and gastrin
Arterial plasma concentrations of total GLP-1 increased dur-
ing glucose + NaCl and glucose alone, however, an apparent 
plateau (incremental AUC, lasting from 40–80 min) was sig-
nificantly higher during glucose + NaCl compared with glu-
cose alone (Figure 4a). Arterial plasma concentrations of GIP 
increased on both days and no statistically significant differ-
ences between the days were observed (Figure 4b). Arterial 
plasma concentrations of CCK and gastrin increased on both 
days and no statistically significant differences between the 
days were observed (Figure 5a and b).
3.5 | Effect of glucose and sodium chloride 
intake on the renin-angiotensin-aldosterone 
system and natriuretic peptides
Arterial plasma concentrations of ANG II were signifi-
cantly lower from 60–80  min (incremental AUC) during 
glucose + NaCl compared with glucose alone (Figure 6b). 
Arterial plasma concentrations of renin and aldosterone re-
mained unchanged on both days and no significant differ-
ences between the days were observed (Figure  6a and c, 
respectively). Arterial plasma concentrations of proANP, 
ANP, and BNP remained unchanged on both days and no 
statistically significant differences between the days were ob-
served (Figure 7a-c).
4 |  DISCUSSION
This study supports the hypothesis, that postprandial physi-
ological GLP-1 responses in humans were enhanced selec-
tively by increased dietary sodium chloride (NaCl) intake 
when compared with other nutrient-sensitive GI hormones. 
GLP-1 secretion from the small intestine normally increases 
following nutrient intake, and dietary carbohydrates are 
major determinants of GLP-1 secretion (Gribble et al., 2003; 
Reimann & Gribble, 2002). There is evidence, that the main 
mechanism behind this is glucose uptake in the enteroendo-
crine L-cells mediated via sodium-glucose cotransporter 1 
(SGLT1) (Gribble et al., 2003; Reimann & Gribble, 2002). 
Under physiological circumstances it would not be expected 
that sodium availability is rate-limiting for glucose absorption 
F I G U R E  2  Arterial plasma concentrations of (a) glucose, (b) 
insulin, and (c) C-peptide after a 75-gram oral glucose load (75 g of 
glucose) with a 6-gram oral sodium chloride load (6 g of NaCl) (filled 
circles) or 75 g of glucose alone (open circles) from 0 to 140 min. Data 
are presented as means ± SE
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and thereby GLP-1 secretion (because of the high abundance 
of sodium in the diet and the bile and gastropancreatic se-
cretions). Addition of NaCl to the meal increases the osmo-
larity of the meal, which could be a contributory factor to 
the increased GLP-1 secretion mediated by the electrogenic 
nature of Na+-coupled glucose uptake by SGLT1, highly ex-
pressed in L-cells (Gribble et al., 2003). Thus, SGLT1 is an 
L-cell glucose sensor, utilizing the inwardly directed sodium 
gradient to drive glucose influx which stimulates GLP-1 se-
cretion to the circulation. Our results indicate that SGLT1 
may indirectly act as an L-cell sodium sensor in which in-
creased dietary, and thus luminal sodium, amplifies glu-
cose/sodium-dependent GLP-1 secretion. This is supported 
by the present study in which arterial levels of sodium in-
creased during both study days, however, the increase was 
significantly larger during an oral glucose + NaCl load com-
pared with glucose load alone, whereas chloride levels only 
increased during glucose + NaCl and remained unchanged 
during glucose alone. Thus, these different effects on plasma 
sodium and chloride levels most likely reflect the NaCl load-
ing by ~ 100 mmol. From this study, we cannot determine 
whether the same feed-forward GLP-1 secretion was seen if 
the same amount of NaCl was given but at a concentration at, 
or lower than, that of plasma. It remains unclarified whether 
plasma sodium concentrations need to rise in order to be 
sensed or is it solely driven by a luminal sensing of ingested 
F I G U R E  3  Arterial plasma concentrations of (a) sodium, (b) chloride, (c) hydrogen, (d) potassium, (e) calcium, and (f) hematocrit after a 
75-gram oral glucose load (75 g of glucose) with a 6-gram oral sodium chloride load (6 g of NaCl) (filled circles) or 75 g of glucose alone (open 
circles) from 0 to 140 min. *, statistically significant differences (p < .05) between incremental integrated concentrations. Data are presented as 
means ± SE
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sodium, e.g. an acute splanchnic input sensor/monitor for so-
dium intake. However, in healthy volunteers, intraduodenal 
hyperosmolar saline (1,500  mOsm/L) increased circulatory 
GLP-1 levels (physiological plasma levels), peaking around 
60 min compared with an isoosmolar solution (300 mOsm/L) 
(Veedfald et al., 2018).
The increased GLP-1 plasma concentrations observed 
during NaCl loading is consistent with the hypothesis that 
there is a GLP-1-mediated feed-forward natriuretic effect 
since it was associated with lower circulating plasma levels 
of ANG II, a major determinant of renal sodium excretion. 
The significantly lower ANG II concentrations were indepen-
dent of renin, aldosterone, and proANP/ANP/BNP levels as 
well as glucose and insulin levels. This is in line with pre-
vious human studies (Asmar et al., 2019; Skov et al., 2013) 
that demonstrated a significant natriuretic effect during ex-
ogenous GLP-1 infusions – reaching physiological levels in 
2–3-hr periods – when the extracellular fluid volume (ECV) 
was expanded by intravenous sodium loading. In these stud-
ies, there was a suppression of ANG II with no change in 
renal plasma flow and glomerular filtration rate, pointing to a 
tubular mechanism for reduced NaCl reabsorption secondary 
to the ANG II suppression. The mechanism by which GLP-1 
reduces ANG II has not been shown. One explanation may 
be a direct inhibition of ACE-mediated ANG II synthesis in 
tissues (Asmar et al., 2019; Skov et al., 2013).
In other studies of healthy participants (Asmar et al., 2015) 
and patients with type 2 diabetes (Asmar et al., 2016) without 
intravenous ECV expansion, we were unable to demonstrate 
a GLP-1-induced natriuretic effect. The effect is thus associ-
ated with the physiological need to excrete excess sodium and 
mild expansion of ECV to an extent that does not alter natri-
uretic peptides. This is in line with previous human studies 
(Preston et al., 2012) demonstrating that ECV expansion is 
important in eliciting a rapid-acting, feed-forward natriuretic 
mechanism.
Together, the observations suggest the existence of a 
causal relationship that needs to be verified by direct experi-
ments. The luminal sensing of ingested sodium suggests the 
presence of a splanchnic input sensor/monitor for sodium 
which modulates renal sodium excretion.
Several other gut-derived hormones have been pro-
posed to influence renal function and electrolyte balance 
as reviewed comprehensively (Jose et al., 2016; Michell 
et al., 2008; Muskiet et al., 2017; Thomas & Kumar, 2008; 
Yang et al., 2017). Thus, animal and human models have 
F I G U R E  4  Arterial plasma concentrations of (a) GLP-1 and 
(b) GIP after a 75-gram oral glucose load (75 g of glucose) with a 
6-gram oral sodium chloride load (6 g of NaCl) (filled circles) or 
75 g of glucose alone (open circles) from 0 to 140 min. *, statistically 
significant differences (p < .05) between steady state incremental 
integrated concentrations. Data are presented as means ± SE
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F I G U R E  5  Arterial plasma concentrations of (a) CCK and (b) 
gastrin after a 75-gram oral glucose load (75 g of glucose) with a 
6-gram oral sodium chloride load (6 g of NaCl) (filled circles) or 75 g 
of glucose alone (open circles) from 0 to 140 min. Data are presented 
as means ± SE
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shown that supraphysiological infusions of both gastrin 
and CCK may induce natriuresis (Calam et al., 1987; Chen 
et al., 2013; Ladines et al., 2001) associated with decreased 
sodium–hydrogen antiporter 3 activity (Liu & Jose,  2013; 
Liu et al., 2016) and decreased plasma renin activity (Calam 
et  al.,  1987). Furthermore, at least in rats, gastrin may be 
released from the upper intestine into the circulation in re-
sponse to sodium intake, and subsequent activation of renal 
gastrin receptors may act synergistically with renal dopamine 
receptors to increase sodium excretion (Chen et al., 2013).
Recently, it was demonstrated that a hyperosmolar 
load alone increases CCK secretion in humans (Veedfald 
et al., 2018). However, the present observation of similar 
responses to NaCl intake with glucose compared to glu-
cose alone in humans makes it less likely that CCK is the 
signal that promotes the additional renal sodium excretion. 
Thus, the present data show that CCK and gastrin are not 
likely sensors (or effectors) of an (additional) oral NaCl 
load in humans under postprandial conditions. In human 
studies, experiments are needed, generally to investigate 
causal involvement of ‘intestinal natriuretic peptides’, e.g., 
uroguanylin as well as guanylin, primarily expressed in 
the mammalian intestine but also in the kidney (Lorenz 
et al., 2003; Potthast et al., 2001). Findings in rodents es-
tablish a role for uroguanylin in a gut-kidney axis (Lorenz 
et al., 2003; Potthast et al., 2001).
F I G U R E  6  Arterial plasma concentrations of (a) renin, (b) 
angiotensin II, and (c) aldosterone after a 75-gram oral glucose load 
(75 g of glucose) with a 6-gram oral sodium chloride load (6 g of 
NaCl) (filled circles) or 75 g of glucose alone (open circles) from 0 
to 140 min. *, statistically significant differences (p < .05) between 
steady state incremental integrated concentrations. Data are presented 
as means ± SE
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F I G U R E  7  Arterial plasma concentrations of (a) proANP, (b) 
ANP, and (c) BNP after a 75-gram oral glucose load (75 g of glucose) 
with 6-gram oral sodium chloride load (6 g of NaCl) (filled circles) 
or 75 g of glucose alone (open circles) from 0 to 140 min. Data are 
presented as means ± SE
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5 |  LIMITATIONS OF THE STUDY
In this study we specifically aimed to investigate whether 
postprandial GLP-1 secretion compared with the secretion 
of other nutrient-sensitive GI hormones is sensitive to an 
increased NaCl intake. This hypothesis was confirmed as a 
first step. Whether 10  pmol/L (20%) difference in plasma 
GLP-1 between participants ingesting glucose + NaCl ver-
sus glucose alone is physiologically relevant, and whether the 
observed inverse relationship between GLP-1 and ANG II 
concentrations is causal in the promotion of urinary sodium 
excretion was not determined in this observational study 
and only inferred by ANG II concentrations. Future studies 
should investigate renal sodium and other electrolyte excre-
tions for longer than 2 hr following similar ingestion proto-
cols and involve blockers of GLP-1 receptors and/or clamped 
levels of ANG II and ANG II receptor type 1 (AT1) blockers. 
Additional studies should be conducted, using oral solutions 
matched for osmolarity. In this study, participants were given 
an NaCl loading of ~ 100 mmol in a solution of 200 mmol/L 
as an add-on to 75 grams of glucose only during one study 
day.
Differences in gastric emptying rate should also be con-
sidered because of their powerful effects on postprandial hor-
mone and nutrient responses, but this appears less likely since 
initial plasma responses of all the gut hormones measured as 
well as glucose absorption profiles were similar between the 
two study days.
We studied healthy young men, and the more general sig-
nificance of our findings will need to be tested in a wider 
range of participants, since studies demonstrate that healthy 
women have a higher postprandial GLP-1 response than men 
(Faerch et al., 2015).
6 |  CONCLUSIONS
In summary, we show that an oral glucose load with added 
NaCl elicited a larger increase in plasma level of GLP-1, 
whereas GIP, gastrin and CCK levels were affected similarly. 
The larger increase in plasma level of GLP-1 was associated 
with lower plasma level of ANG II. It is concluded that die-
tary sodium content inversely influences postprandial GLP-1 
and ANG II plasma levels.
6.1 | Perspectives
In perspective, GLP-1 could potentially support a positive 
feed-forward natriuresis that may be secondary to lower 
ANG II levels. This mechanism could have significant im-
plications for renal sodium handling in health and disease, 
since there is an impaired incretin secretion and action in 
obesity and type 2 diabetes. Thus, impaired GLP-1 sensing 
may link salt sensitivity with insulin-resistance, increased 
sympathetic nervous activity, and ultimately the develop-
ment of hypertension.
It is interesting that in patients with type 2 diabetes – with 
high risk of cardiovascular and renal events – treatment with 
GLP-1 receptor agonists and to a lesser extent with DPP-4 
inhibitors in addition to standard treatment of diabetes has 
proven to have beneficial long-term cardiovascular and renal 
effects – plausibly beyond the effects of glycemic control 
(Muskiet et  al., 2017). The beneficial effects of the GLP-1 
receptor agonists might represent restoration of the gut-kid-
ney cross talk.
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